| Kisiel, John |
Mayo Clinic Rochester
United States |
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation |
5R37CA214679-07 |
|
Matthew Young, Ph.D. |
| Kleckner, Ian Robert |
University Of Maryland Baltimore
United States |
Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation |
5R21CA259422-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
| Kober, Kord Michael |
University Of California, San Francisco
United States |
An Evaluation of Cloud Computing for Symptom Science Research: Moving Genomics and Machine Learning Analyses of Cancer Chemotherapy-Related Fatigue to the Cloud |
3R37CA233774-05S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Kong, Mei |
University Of California-Irvine
United States |
Using dietary glutamine supplementation for melanoma prevention and targeted therapy |
5R01CA244360-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Gabriela Riscuta, M.D., C.N.S. |
| Kooperberg, Charles L |
Fred Hutchinson Cancer Center
United States |
Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) |
1UG1CA287013-01 |
|
Elyse LeeVan, M.D., M.P.H. |
| Krasnow, Mark A |
Stanford University
United States |
Molecular mechanisms of SCLC initiation and detection in mice and humans |
5U01CA231851-05 |
|
Eva Szabo, M.D. |
| Krist, Alexander H |
Virginia Commonwealth University
United States |
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) |
1UG1CA287017-01 |
|
Elyse LeeVan, M.D., M.P.H. |
| Kroetz, Deanna L |
Ohio State University
United States |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity |
5R01CA261068-05 |
|
Rachel Altshuler, Ph.D. |
| Kuhn, Peter |
University Of Southern California
United States |
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma |
1U01CA285013-01 |
|
|
| Kuhs, Krystle A. |
University Of Kentucky
United States |
Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer |
5R21CA267152-02 |
|
Wendy Wang, Ph.D., M.Sc. |